US Broker Ratings

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Strategic Collaborations and Growth Potential in Biotechnology

In the rapidly evolving landscape of biotechnology, Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands out as a frontrunner committed to transforming drug discovery through the integration of..

10x Genomics, Inc. (TXG) Investor Outlook: Exploring a 13.32% Potential Upside in the Healthcare Sector

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare industry, operates in the dynamic field of health information services. The company is headquartered in..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Unveiling a 24.95% Potential Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) emerges as a compelling player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $3.42 billion,..

MiMedx Group, Inc (MDXG) Investor Outlook: Discovering an 80% Potential Upside in the Healthcare Sector

MiMedx Group, Inc (MDXG) is making waves in the healthcare sector, particularly in the biotechnology industry, with its innovative approach to wound care and surgical products...

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A 127% Potential Upside Fuels Investor Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), headquartered in San Diego, California, is making waves in the biotechnology sector with its focus on novel therapeutics for rare endocrine..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Unpacking a 35.62% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the healthcare sector, specifically within the medical care facilities industry, offers a range of specialized services..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a Potential 116% Upside in Biotech

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands as a notable player in the biotechnology sector, focusing on addressing rare kidney and metabolic diseases. With a market capitalization..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a Potential 134% Upside in Biotech Innovation

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of the biotechnology sector with a focus on precision medicine oncology. The company is dedicated to discovering..

SS Innovations International (SSII) Stock Analysis: A Closer Look at Its Growth Potential Amidst a 40.8% Revenue Surge

SS Innovations International, Inc. (SSII), a burgeoning player in the healthcare sector specializing in medical devices, is making waves in the market with its innovative approach..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 41.45% Potential Upside with Strong Buy Ratings

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is capturing investor attention with its strong growth trajectory and promising upside potential...

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 17.90% Potential Upside in the Healthcare Sector

GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare sector with its innovative approach to cancer detection and diagnostics. Headquartered in Menlo Park, California, this..

Twist Bioscience Corporation (TWST) Stock Analysis: A 39% Potential Upside in the Synthetic DNA Market

Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of the synthetic DNA industry, crafting a niche in the rapidly evolving healthcare sector. With its headquarters..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 16% Upside Potential Amid Strong Revenue Growth

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has been making waves in the biotechnology sector, particularly attracting attention with its potential upside of 16.01%. As a Canadian biopharmaceutical..

89bio, Inc. (ETNB): Analyst Consensus Points to a 191% Upside Potential

For investors with a focus on the biotechnology sector, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing proposition. With a market capitalization of $1.48 billion, this San..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Bet with 79% Potential Upside

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity. With a market capitalization of $1.75 billion, the..

Liquidia Corporation (LQDA)

⚠️ No article content returned.

..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Potential 114.83% Upside

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, specifically in the realm of medical devices, is capturing investor attention with its substantial potential..

Bausch Health Companies Inc. (BHC): Investor Outlook and 12% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC) presents an intriguing opportunity for investors eyeing the healthcare sector. With a market capitalization of $2.34 billion, this Canadian pharmaceutical..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Investor Outlook with 17.74% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the Healthcare sector, operates within the Medical Care Facilities industry. With a market capitalization nearing $929..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring a 46.96% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering player in the healthcare sector, is attracting investor attention with its innovative bioelectric medicine solutions. Specializing in the development..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds